Delivery Order SPE2DB24D1104-SPE2DB24FXYB0
Award Date
5/14/24
Potential Completion Date
5/15/24
Potential Value
$3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of XELJANZ 10 MG TABLET UU 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $45,705.77 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract has an ultimate completion date of August 15, 2024 and was awarded on August 14, 2024. It is not designated as a set-aside contract. This delivery order...
This federal contract award is for the delivery of XELJANZ 5 MG TABLET UU 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $5,376.31, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 13, 2024 with a completion date of June 14, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued up to $999,999,999.00 through December 31, 2025....
This federal contract award is for the delivery of XELJANZ 5 MG TABLET UU 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on February 27, 2025, with a ceiling value of $7,053.98 and an ultimate completion date of February 28, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the...
This federal contract award is for the delivery of XELJANZ XR 11 MG TABLET UU 30S pharmaceutical products to the Defense Logistics Agency (DLA). The $26,963.82 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distributor and healthcare solutions provider. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. (doing business as AmerisourceBergen) with the DLA Troop Support Medical, which serves as...
This federal contract award, valued at $22,451.41, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XELJANZ XR 11 MG TABLET UU 30S, a pharmaceutical product. This award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award is for the delivery of pharmaceutical products, specifically the drug XELJANZ 5 MG TABLET, to the Defense Logistics Agency (DLA). The $3,722.97 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a pharmaceutical distribution company. The contract has a ceiling value of $3,722.97 and an ultimate completion date of February 23, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent...
This federal contract award, valued at $12,385.26, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XELJANZ XR 11 MG TABLET UU 30S, a specialty medication. The award is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,744.98 Firm Fixed Price Delivery Order is for the supply of XELJANZ 5 MG TABLET UU 60S, a pharmaceutical product. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,240.29 delivery order is for the supply of XELJANZ 5 MG TABLET, a prescription medication used to treat certain autoimmune conditions. The contract has a firm fixed price and an ultimate completion date of December 2, 2022. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA). The $5,896.86 firm-fixed-price delivery order is for XELJANZ 5 MG TABLET UU 60S, a pharmaceutical product. The contract has an ultimate completion date of November 22, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as...